Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Stem Cells (Dayton, Ohio)|October 1, 1993
Newer approaches in treating chronic myelogenous leukemiaS Gulati, R Lemoli, M FraigLeukemia & Lymphoma|January 1, 1993
Newer approaches in treating chronic myelogenous leukemiaS C Gulati, R Lemoli, C Van PoznakBone Marrow Transplantation|June 1, 2011
Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo OsseoA Olivieri, M Marchetti, R Lemoli, et al.British Journal of Haematology|May 12, 1998
Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studiesA Bolognesi, P L Tazzari, F Olivieri, et al.Cancer Research|August 14, 1999
Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cellsR Manfredini, F Trevisan, A Grande, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantationS Gulati, J Yahalom, L Acaba, et al.Bone Marrow Transplantation|September 14, 1999
Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cellsG Visani, R Lemoli, P Tosi, et al.Haematologica|September 12, 2000
Polymerase chain reaction-based detection of minimal residual disease in multiple myeloma patients receiving allogeneic stem cell transplantationG Martinelli, C Terragna, E Zamagni, et al.Leukemia Research|July 7, 2015
Age and comorbidities deeply impact on clinical outcome of patients with myelodysplastic syndromesE Balleari, C Salvetti, L Del Corso, et al.Pageof 1